Andrew Moin
Direktor/Vorstandsmitglied bei SAB BIOTHERAPEUTICS, INC.
Profil
Andrew Moin is currently the Director at SAB Biotherapeutics, Inc. and an Analyst at Sessa Capital IM LP.
He is also a Member at The New York Bar Foundation.
Mr. Moin completed his undergraduate degree at Amherst College in 2005 and his graduate degree at Harvard Law School in 2008.
Aktive Positionen von Andrew Moin
| Unternehmen | Position | Beginn |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.10.2023 |
Sessa Capital IM LP
 Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles. | Analyst-Equity | 01.08.2012 |
| The New York Bar Foundation | Corporate Officer/Principal | - |
Ausbildung von Andrew Moin
| Amherst College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| The New York Bar Foundation | |
Sessa Capital IM LP
Sessa Capital IM LP Investment ManagersFinance Sessa Capital IM LP (Sessa Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by John Petry in 2007. Sessa Capital provides investment advisory and management services on a discretionary basis to private pooled investment vehicles. | Finance |
